Actively Recruiting

Age: 18Years +
MALE
NCT07516886

Prognostic Value of Early Postoperative Prostate-Specific Antigen for Oncological Outcomes After Radical Prostatectomy

Led by Lithuanian University of Health Sciences · Updated on 2026-04-08

500

Participants Needed

1

Research Sites

805 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This prospective observational study aims to evaluate the prognostic significance of early postoperative prostate-specific antigen (PSA) levels in patients undergoing radical prostatectomy for prostate cancer. No investigational interventions will be performed. All diagnostic procedures, follow-up assessments, and treatments will be conducted in accordance with standard clinical practice and established prostate cancer management guidelines. Participation in the study will not influence treatment decisions.

CONDITIONS

Official Title

Prognostic Value of Early Postoperative Prostate-Specific Antigen for Oncological Outcomes After Radical Prostatectomy

Who Can Participate

Age: 18Years +
MALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Patient is an adult biological male.
  • Patient has morphologically confirmed and untreated prostate cancer.
  • Patient will be treated with open, laparoscopic, or robot-assisted laparoscopic radical prostatectomy.
  • Patient is informed about this observational study and has signed the informed consent form.
Not Eligible

You will not qualify if you...

  • Patient has radiologically or morphologically confirmed prostate cancer metastases before the operation.
  • Patient received neoadjuvant prostate cancer treatment.
  • Patient is set to receive adjuvant treatment.
  • Patient has any contraindications for the operation.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Lithuanian University of Health Sciences Hospital Kaunas Clinics, Department of Urology

Kaunas, Kauno, Lithuania, LT-50161

Actively Recruiting

Loading map...

Research Team

G

Gustas Sasnauskas, MD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Prognostic Value of Early Postoperative Prostate-Specific Antigen for Oncological Outcomes After Radical Prostatectomy | DecenTrialz